Cargando…

Preempting Bronchopulmonary Dysplasia: Time to Focus on the Placenta?

Detalles Bibliográficos
Autor principal:	Thébaud, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803361/ https://www.ncbi.nlm.nih.gov/pubmed/34748718 http://dx.doi.org/10.1165/rcmb.2021-0472ED

Ejemplares similares

The Therapeutic Potential of Stem Cells for Bronchopulmonary Dysplasia: “It’s About Time” or “Not so Fast” ?
por: Ee, Mong Tieng, et al.
Publicado: (2018)

Stem Cells and Their Mediators – Next Generation Therapy for Bronchopulmonary Dysplasia
por: Möbius, Marius A., et al.
Publicado: (2015)

Impact of bronchopulmonary dysplasia on brain and retina
por: Poon, Annie Wing Hoi, et al.
Publicado: (2016)

Cell-Based Strategies to Reconstitute Lung Function in Infants with Severe Bronchopulmonary Dysplasia
por: O'Reilly, Megan, et al.
Publicado: (2012)

Strategies to improve outcomes of bronchopulmonary dysplasia
por: Jung, Young Hwa, et al.
Publicado: (2019)

Using Cell-Based Strategies to Break the Link between Bronchopulmonary Dysplasia and the Development of Chronic Lung Disease in Later Life
por: O'Reilly, Megan, et al.
Publicado: (2013)

Perinatal origins of bronchopulmonary dysplasia—deciphering normal and impaired lung development cell by cell
por: Mižíková, I., et al.
Publicado: (2023)

Bronchopulmonary Dysplasia: Endothelial Cells in the Driver’s Seat
por: Vohwinkel, Christine U., et al.
Publicado: (2021)

Revisiting the Role for HIF Stabilizers in Bronchopulmonary Dysplasia
por: Boucherat, Olivier, et al.
Publicado: (2020)

The Wnt Signaling Pathway and the Development of Bronchopulmonary Dysplasia
por: Lingappan, Krithika, et al.
Publicado: (2020)

Disease Phenotyping of Infants with Severe Bronchopulmonary Dysplasia
por: Mandell, Erica, et al.
Publicado: (2020)

Can biomarkers be used to predict bronchopulmonary dysplasia?()
por: Bhandari, Vineet, et al.
Publicado: (2020)

Leveraging Microbial Symbiosis to Modulate Bronchopulmonary Dysplasia
por: Peterson, Laura S., et al.
Publicado: (2022)

Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study
por: van Katwyk, Sasha, et al.
Publicado: (2020)

Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta‐Analysis of Preclinical Studies
por: Augustine, Sajit, et al.
Publicado: (2017)

Headache symptoms of the PREEMPT population
por: Dodick, DW, et al.
Publicado: (2013)

Early Detection of Pulmonary Vascular Dysfunction in Neonatal Bronchopulmonary Dysplasia
por: Hassoun, Paul M.
Publicado: (2020)

Lessons Learned to Promote Lung Cancer Screening and Preempt Worsening Lung Cancer Disparities
por: Burnett-Hartman, Andrea N., et al.
Publicado: (2020)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Lung function in adults born prematurely with bronchopulmonary dysplasia
por: Chen, I-Ling, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: A Continuum of Lung Disease from the Fetus to the Adult
por: Jobe, Alan H., et al.
Publicado: (2019)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Intermittent Hypoxemia and Bronchopulmonary Dysplasia: Manifestations of Immature Respiratory Control and the Preterm Lung
por: Di Fiore, Juliann M., et al.
Publicado: (2021)

Mesenchymal Cells and Bronchopulmonary Dysplasia: New Insights about the Dark Side of Oxygen
por: Popova, Antonia P.
Publicado: (2019)

New Imaging Tools Allow Bronchopulmonary Dysplasia to Enter the Age of Precision Medicine
por: Shepherd, Edward G., et al.
Publicado: (2020)

rhIGF-1 Therapy: A Silver Bullet for Bronchopulmonary Dysplasia Prevention?
por: Plosa, Erin J., et al.
Publicado: (2020)

Does a Pandemic Preempt Participatory Medicine?
por: Millenson, Michael Louis
Publicado: (2020)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

Oxidative Stress and Bronchopulmonary Dysplasia
por: Perrone, Serafina, et al.
Publicado: (2012)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology
por: Dankhara, Nilesh, et al.
Publicado: (2023)

Mesenchymal Stromal Cell Extracellular Vesicles: A New Approach for Preventing Bronchopulmonary Dysplasia?
por: Klinger, James R., et al.
Publicado: (2022)

Are all stem cells equal? Systematic review, evidence map, and meta‐analyses of preclinical stem cell‐based therapies for bronchopulmonary dysplasia
por: Augustine, Sajit, et al.
Publicado: (2019)

A Review of Placenta and Umbilical Cord-Derived Stem Cells and the Immunomodulatory Basis of Their Therapeutic Potential in Bronchopulmonary Dysplasia
por: Chia, Wai Kit, et al.
Publicado: (2021)

Early Detection for Right Ventricular Dysfunction in Bronchopulmonary Dysplasia without Pulmonary Hypertension
por: Son, Jung-Woo
Publicado: (2016)

p16 (INK4a) and the Alveolar Niche Take Center Stage in Bronchopulmonary Dysplasia
por: Chao, Cho-Ming, et al.
Publicado: (2020)

DDR1 Deficiency in Mice: A Spontaneous Model of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension?
por: Çataltepe, Sule, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t0mapcdiimdegju559sddlnoj5